Filter
925
Text search:
adverse
drug
reactions
Featured
Recommendations
123
New Publications
257
Language
Document type
No document type
573
Guidelines
168
Studies & Reports
87
Manuals
52
Strategic & Response Plan
15
Fact sheets
11
Training Material
10
Brochures
3
Situation Updates
3
Resource Platforms
1
Infographics
1
Countries / Regions
India
70
Kenya
28
South Africa
28
Ethiopia
27
Tanzania
23
Western and Central Europe
21
Uganda
20
Global
20
Nigeria
18
Zambia
17
Malawi
16
Nepal
15
Ghana
14
Philippines
10
Bangladesh
10
Namibia
10
Latin America and the Carribbean
10
Eastern Europe
10
Zimbabwe
9
Cambodia
9
Sierra Leone
8
Liberia
8
Myanmar / Burma
8
Africa
7
Rwanda
6
Botswana
6
Eswatini/ Swaziland
5
South–East Asia Region
5
USA
4
South Sudan
3
Germany
3
Syria
3
Indonesia
3
Brazil
3
Ukraine
3
Sri Lanka
3
Western Pacific Region
3
Congo, Democratic Republic of
2
Haiti
2
Thailand
2
Argentina
2
Colombia
2
Bolivia
2
Lesotho
2
Asia
2
Timor Leste/ East Timor
2
Russia
2
Senegal
1
Mali
1
Cameroon
1
Iraq
1
Lebanon
1
Chad
1
Gambia
1
China
1
Ireland
1
Mozambique
1
Benin
1
Angola
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Solomon Islands
1
Bhutan
1
North Korea
1
Laos
1
Australia
1
Georgia
1
Vietnam
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
359
Clinical Guidelines
133
Public Health
45
Women & Child Health
26
Key Resources
18
Capacity Building
13
Pharmacy & Technologies
12
Toolboxes
TB
135
Mental Health
79
HIV
78
Pharmacy
66
NTDs
50
COVID-19
34
AMR
27
Caregiver
18
Ebola & Marburg
17
Malaria
16
NCDs
14
Refugee
10
Polio
8
Conflict
8
Rapid Response
7
Specific Hazards
5
Natural Hazards
4
Planetary Health
4
Disability
3
Cholera
3
Zika
3
Global Health Education
3
2.0 Rapid Response
3
Health Financing Toolbox
1
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 37.
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initi
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Therapeutics Information and Pharmacovigilance Centre | TIPC
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy
...
